Infectociprocort

Ciprofloxacin and Fluocinolone Acetonide, the active ingredients in Infectociprocort, are a fluoroquinolone antibiotic and a corticosteroid presented as a combined formulation for auricular use. They treat bacterial ear infections and reduce associated inflammation in patients of all ages.

GNH USA supplies Infectociprocort as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infectociprocort acts on bacterial and inflammatory processes of the external ear, providing targeted therapy for ear conditions.

- Otitis externa: eliminates causative bacteria and reduces swelling and pain in the ear canal. - Bacterial ear infection: eradicates susceptible pathogens while controlling local inflammation. - External ear canal inflammation: alleviates redness, itching and discomfort associated with infection.

Infectociprocort may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Ear discomfort or burning sensation. - Mild itching or irritation at the application site. - Transient hearing changes such as muffled sounds. - Dryness or flaking of the ear canal skin. - Temporary increased ear discharge. - Mild headache.

Serious or Rare Side Effects: - Allergic reaction including rash, swelling or anaphylaxis. - Severe ototoxicity leading to permanent hearing loss. - Perforation of the tympanic membrane. - Secondary bacterial or fungal infection of the ear. - Systemic fluoroquinolone effects such as tendon rupture. - Central nervous system effects like seizures (rare).

Before using Infectociprocort, consider the following safety measures.

- Assess tympanic membrane integrity: avoid use if perforation is present. - Allergy screening: do not use in patients with known ciprofloxacin or corticosteroid hypersensitivity. - Monitor systemic fluoroquinolone effects: watch for tendon pain, joint issues, or neurological symptoms. - Limit duration: follow prescriber guidance to reduce risk of resistance and local irritation. - Use in children only when prescribed: pediatric safety data are limited. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Infectociprocort can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Antacids or supplements containing magnesium/aluminum: reduce ciprofloxacin absorption. - Warfarin: may increase bleeding risk. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened risk of tendon injury. - Systemic corticosteroids: may amplify immunosuppressive effects. - Live vaccines: potential reduction in vaccine efficacy.

Moderate Interactions (Monitor Closely): - Other otic preparations: assess cumulative local irritation. - CYP1A2 inhibitors (e.g., fluvoxamine): may increase ciprofloxacin levels. - Diuretics (e.g., furosemide): monitor for electrolyte disturbances. - Oral fluoroquinolones: avoid concurrent systemic exposure. - Antihistamines: may mask early signs of allergic reaction.